Loading…

Alemtuzumab as first‐ and second‐line treatment in patients with Sézary syndrome—The experience of a tertiary centre

Saved in:

Bibliographic Details
Published in:	Journal of the European Academy of Dermatology and Venereology 2024-01, Vol.38 (1), p.e86-e88
Main Authors:	Nogueira, Miguel, Lau, Catarina, Teixeira, Maria dos Anjos, Peixeiro, Rita, Cabral, Renata, Fernandes, Iolanda
Format:	Article
Language:	English
Subjects:	Alemtuzumab - therapeutic use Antibodies, Monoclonal - therapeutic use Antineoplastic Agents - therapeutic use Humans Sezary Syndrome - drug therapy Skin Neoplasms - chemically induced Skin Neoplasms - drug therapy
Citations:	Items that this one cites
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!